Ivantis, Inc.

Release Summary

Ivantis Completes Enrollment in Pivotal HYDRUS IV Glaucoma Study of the Hydrus™ Microstent; Clinical Milestone is Major Step Forward to FDA Review of Innovative and Less Invasive Glaucoma Technology

Ivantis, Inc.